Hanfang Pharmaceutical leads TCM towards modernization and internationalization
2021-12-08 15:14:53 Newsgd.com Newsgd.com
Guangzhou Hanfang Pharmaceutical Co., Ltd., one of GPHL's subsidiaries, integrates technological elements into the development of traditional Chinese medicine (TCM) and makes full use of technology to realize the modernization and standardization of TCM.
The prerequisite for standardization is to produce high-quality raw materials. Hanfang Pharmaceutical has built a new planting demonstration in Tibet's Nyingchi for high-yielding Tibetan ganoderma lucidum, a spore originally found on hardwood trees. Nyingchi features unique natural resources and ecological environment, with an altitude of 2,700 meters, fresh air, clean water, nutrient soil and a forest coverage rate of over 70%. These favorable conditions, coupled with scientific cultivation methods, work together to produce excellent ganoderma lucidum rich in nutrients.
In addition to high-quality raw materials, advanced extraction process is also needed. The Ganoderma Lucidum Spore Oil is developed by the National Engineering Research Center for Modernization of TCM Extraction and Separation Process. In the extraction, the patented technology of supercritical carbon dioxide extraction is used to extract the effective nutrients of broken spore powders, which has a higher content of core nutrients.
Hanfang Pharmaceutical has joined hands with renowned universities from both China and abroad to conduct in-depth research on the drug resistance of the anti-tumor cells in its Ganoderma Lucidum Spore Oil. The Company also carries out pharmacodynamics researches on an array of areas such as the adverse reactions of the Ganoderma Lucidum Spore Oil to radiotherapy and chemotherapy, immune rehabilitation, the improvement of tolerance and the prolongation of survival duration.
The concept of "Trendy TCM" proposed by GPHL, the parent company of Hanfang Pharmaceutical, uses the most advanced scientific research technologies and the most popular marketing approaches to create health care products that are most needed by the general public. This concept is now standing at the forefront in this industry nationwide.
Hanfang Pharmaceutical has donated its Ganoderma Lucidum Spore Oil for free to the medical workers who worked at the front line during the outbreak of COVID-19 in Wuhan and Guangzhou, helping them to defense themselves during the fight against the pandemic. In response to the call of assisting the development of Tibetan areas, the Pharmaceutical built a planting demonstration of ganoderma lucidum in Tibet's Nyingchi, which has increased the income of the locals by more than 10 times.
In October, in the signing ceremony jointly held by GPHL and the World Animal Protection, Hanfang Pharmaceutical officially joined the public welfare initiative of "Protecting Wild Animals with Medicine". Based on this initiative, the Company will take practical action steps to support the construction of ecological civilization, and protect wild animals. It will not develop, produce or sell wildlife-based products, actively undertaking the social responsibility of protecting ecological diversity.
The Ganoderma Lucidum Spore Oil also plays an active role in the field of livestreaming marketing. According to the latest data released by Menet, a leading platform sharing medicare information, the sale volumes of Ganoderma Lucidum Spore Oil has surged by 240% in 2020, and the brand has accounted for over 27% of the market share due to continuous growth in the past few years.
Since its establishment, Hanfang Pharmaceutical, under the leadership of GPHL, has always taken revitalizing TCM and promoting the modernization and internationalization of TCM as its mission. Through a series of international conferences such as the World Economic Forum, Fortune Global Tech Forum and Boao Forum for Asia, the Ganoderma Lucidum Spore Oil has vigorously unveiled the charm of TCM on the global stage.
In 2018, Hanfang Pharmaceutical presided over the formulation of the International Business Standard for Ganoderma Lucidum Spore Oil, which was the first unified and authoritative industrial standard for this industry. The Standard plays a key role in promoting the process of standardization and internationalization of ganoderma lucidum spore oil.
In 2019, the Ganoderma Lucidum Spore Oil served as the officially designated gift for the Fortune Global Tech Forum. In 2020 and 2021, it was selected as the officially designated VIP gift of the Sino-International Entrepreneurs Federation.
The international version of Ganoderma Lucidum Spore Oil has come into the market for sale in Macao SAR, which is an innovative achievement in the development of TCM heritage in the Guangdong-Hong Kong-Macao Greater Bay Area, as well as an essential step for GPHL to further promote the internationalization of TCM. In the future, Hanfang Pharmaceutical will use GPHL's international headquarter in Macao SAR as a bridgehead to push forward the globalization of TCM, so that more TCM products can benefit people all over the world.
With the COVID-19 pandemic still haunting the whole world currently, the medicare industry faces a crucial period of development. Based on TCM, Hanfang Pharmaceutical will stick to working with its partners around Asia to form a powerful alliance in the field of medicare and public welfare charity to safeguard human health together.
Author | Nancy (intern)
Editor | Monica, Jerry